Back to ZBIO
WELLINGTON MANAGEMENT GROUP LLP → ZBIO
WELLINGTON MANAGEMENT GROUP LLP ZBIO Position History
Zenas BioPharma, Inc. • Healthcare
Quarters held
20
Latest value
$1.7M
Q3 2026
Peak value
$196.4M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $29.7M |
| Q4 2025 | $87K |
| Q4 2025 | $1.3M |
| Q1 2026 | $19.6M |
| Q1 2026 | $102K |
| Q1 2026 | $516K |
| Q1 2026 | $3.9M |
| Q1 2026 | $317K |
| Q2 2026 | $32M |
| Q2 2026 | $32K |
| Q2 2026 | $171K |
| Q2 2026 | $914K |
| Q2 2026 | $6.9M |
| Q2 2026 | $418K |
| Q3 2026 | $196.4M |
| Q3 2026 | $661K |
| Q3 2026 | $307K |
| Q3 2026 | $2.8M |
| Q3 2026 | $16.5M |
| Q3 2026 | $1.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $1.7M | 61.7K | — | — |
| Q3 2026 | $16.5M | 610.5K | — | — |
| Q3 2026 | $2.8M | 104.9K | — | — |
| Q3 2026 | $307K | 11.4K | — | — |
| Q3 2026 | $661K | 24.5K | — | — |
| Q3 2026 | $196.4M | 7.28M | — | — |
| Q2 2026 | $418K | 16.5K | — | — |
| Q2 2026 | $6.9M | 270.7K | — | — |
| Q2 2026 | $914K | 36.0K | — | — |
| Q2 2026 | $171K | 6.7K | — | — |
| Q2 2026 | $32K | 1.3K | — | — |
| Q2 2026 | $32M | 1.26M | — | — |
| Q1 2026 | $317K | 16.2K | — | — |
| Q1 2026 | $3.9M | 197.5K | — | — |
| Q1 2026 | $516K | 26.4K | — | — |
| Q1 2026 | $102K | 5.2K | — | — |
| Q1 2026 | $19.6M | 1.00M | — | — |
| Q4 2025 | $1.3M | 36.0K | — | — |
| Q4 2025 | $87K | 2.4K | — | — |
| Q4 2025 | $29.7M | 816.9K | — | — |
Other funds holding ZBIO
$231.9M
$191.3M
$189.6M
$142.6M
$142.3M
$127.9M